Brief: Redx Pharma Sells KRAS Inhibitor Program

Redx Pharma

07/02/2024 07:28

Feb 7 (Reuters) - Redx Pharma PLC  REDX.L :
    * REDX ANNOUNCES SALE OF KRAS INHIBITOR PROGRAM
    * REDX TO RECEIVE $10 MILLION UPFRONT; POTENTIAL FOR UP TO
$870
MILLION IN DEVELOPMENT, REGULATORY AND SALES MILESTONE PAYMENTS

Source text for Eikon:  ID:nRSG2511Ca 
Further company coverage:  REDX.L 

 ((Reuters.Briefs@thomsonreuters.com;;))